Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission. Issue 3 (7th November 2019)
- Record Type:
- Journal Article
- Title:
- Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission. Issue 3 (7th November 2019)
- Main Title:
- Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission
- Authors:
- Cushing, Kelly C.
Tan, William
Alpers, David H.
Deshpande, Vikram
Ananthakrishnan, Ashwin N. - Abstract:
- Summary: Background: Clinical and endoscopic remission are treatment targets in ulcerative colitis (UC). The value of histologic healing in altering clinical outcomes among patients with complete endoscopic healing is not well established. Aim: To quantify the association between histologic activity and clinical relapse among patients with UC who were in complete endoscopic remission. Methods: This study included patients with UC from a prospective registry who were in complete endoscopic remission. Histologic activity was quantified by a senior gastrointestinal pathologist. Histologic activity was defined as lack of normalisation (Geboes score > 0) as well as histologically active disease (Geboes score ≥2.1 and ≥3.1). The primary outcome was clinical relapse within 2 years. Multivariable regression adjusting for potential confounders examined the independent predictive value of histologic changes. Results: The study included 83 patients (51% women) (median age 44 years; median disease duration 11 years). Forty‐one (49%) had complete histologic normalisation. Within two years, 26 (31%) experienced clinical relapse. Patients with complete histologic normalisation were less likely to experience relapse (5/41, 12%) compared to those without normalisation (21/42, 50%, P < 0.001) (multivariable OR 7.22, 95% confidence interval (CI) 2.48‐24.70) by the Geboes score. The individual components of the Geboes score predictive of relapse were architectural changes ( P = 0.03) andSummary: Background: Clinical and endoscopic remission are treatment targets in ulcerative colitis (UC). The value of histologic healing in altering clinical outcomes among patients with complete endoscopic healing is not well established. Aim: To quantify the association between histologic activity and clinical relapse among patients with UC who were in complete endoscopic remission. Methods: This study included patients with UC from a prospective registry who were in complete endoscopic remission. Histologic activity was quantified by a senior gastrointestinal pathologist. Histologic activity was defined as lack of normalisation (Geboes score > 0) as well as histologically active disease (Geboes score ≥2.1 and ≥3.1). The primary outcome was clinical relapse within 2 years. Multivariable regression adjusting for potential confounders examined the independent predictive value of histologic changes. Results: The study included 83 patients (51% women) (median age 44 years; median disease duration 11 years). Forty‐one (49%) had complete histologic normalisation. Within two years, 26 (31%) experienced clinical relapse. Patients with complete histologic normalisation were less likely to experience relapse (5/41, 12%) compared to those without normalisation (21/42, 50%, P < 0.001) (multivariable OR 7.22, 95% confidence interval (CI) 2.48‐24.70) by the Geboes score. The individual components of the Geboes score predictive of relapse were architectural changes ( P = 0.03) and increased chronic inflammatory infiltrate ( P < 0.001). Conclusions: Complete histologic healing using the Geboes score was associated with reduced rates of clinical relapse among patients with UC in endoscopic remission. Abstract : LINKED CONTENT This article is linked to Pai et al and Cushing et al and Ananthakrishnan papers. To view these articles, visit https://doi.org/10.1111/apt.15617 and https://doi.org/10.1111/apt.15621 . … (more)
- Is Part Of:
- Alimentary pharmacology & therapeutics. Volume 51:Issue 3(2020)
- Journal:
- Alimentary pharmacology & therapeutics
- Issue:
- Volume 51:Issue 3(2020)
- Issue Display:
- Volume 51, Issue 3 (2020)
- Year:
- 2020
- Volume:
- 51
- Issue:
- 3
- Issue Sort Value:
- 2020-0051-0003-0000
- Page Start:
- 347
- Page End:
- 355
- Publication Date:
- 2019-11-07
- Subjects:
- Digestive organs -- Diseases -- Treatment -- Periodicals
Digestive organs -- Effect of drugs on -- Periodicals
Gastrointestinal system -- Diseases -- Treatment -- Periodicals
Gastrointestinal system -- Effect of drugs on -- Periodicals
615.73 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2036 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/apt.15568 ↗
- Languages:
- English
- ISSNs:
- 0269-2813
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0787.886000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 12811.xml